2021
DOI: 10.1080/09537104.2021.2003316
|View full text |Cite
|
Sign up to set email alerts
|

Potential and limitations of PKA/ PKG inhibitors for platelet studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…In addition, we established that VASP phosphorylation stimulated by the tested aglycones may be significantly suppressed by H89, a specific PKA The observed inhibitory effect of these aglycones appeared as time-(1-30 min) and dose-dependent (5-100 µM). In addition, we established that VASP phosphorylation stimulated by the tested aglycones may be significantly suppressed by H89, a specific PKA inhibitor that may also inhibit PKG [75,76] (Figure 8). We concluded that the flavonoid aglycones exhibit antiplatelet effects mediated by the activation of the adenylate cyclase (AC)/cAMP/PKA and/or guanylate cyclase (GC)/cGMP/PKG signaling systems.…”
Section: Flavonoid Aglycones Activate Cyclic Nucleotide-mediated Sign...mentioning
confidence: 88%
See 1 more Smart Citation
“…In addition, we established that VASP phosphorylation stimulated by the tested aglycones may be significantly suppressed by H89, a specific PKA The observed inhibitory effect of these aglycones appeared as time-(1-30 min) and dose-dependent (5-100 µM). In addition, we established that VASP phosphorylation stimulated by the tested aglycones may be significantly suppressed by H89, a specific PKA inhibitor that may also inhibit PKG [75,76] (Figure 8). We concluded that the flavonoid aglycones exhibit antiplatelet effects mediated by the activation of the adenylate cyclase (AC)/cAMP/PKA and/or guanylate cyclase (GC)/cGMP/PKG signaling systems.…”
Section: Flavonoid Aglycones Activate Cyclic Nucleotide-mediated Sign...mentioning
confidence: 88%
“…We concluded that the flavonoid aglycones exhibit antiplatelet effects mediated by the activation of the adenylate cyclase (AC)/cAMP/PKA and/or guanylate cyclase (GC)/cGMP/PKG signaling systems. inhibitor that may also inhibit PKG [75,76] (Figure 8). We concluded that the flavonoid aglycones exhibit antiplatelet effects mediated by the activation of the adenylate cyclas (AC)/cAMP/PKA and/or guanylate cyclase (GC)/cGMP/PKG signaling systems.…”
Section: Flavonoid Aglycones Activate Cyclic Nucleotide-mediated Sign...mentioning
confidence: 99%
“…Activation of PKA/PKG can be monitored by the phosphorylation of their substrate proteins. In platelets, vasodilator-stimulated phosphoprotein (VASP) is an established substrate of these kinases which is phosphorylated by PKA and PKG [26]. Flavonoids could modulate cyclic nucleotide concentrations in different cell types, including platelets [27].…”
Section: Accepted Manuscriptmentioning
confidence: 99%